Answer:
he can try to relax a little bit and then he can make a calendar so evrey thing has time
Explanation:
Answer:
Two different ways in which antiretroviral drugs can prevent the formation of new viruses are:
- Inhibiting the reverse transcriptase enzyme in both nucleoside analogues and non-nucleoside analogues.
- Enzymatic inhibition of integrase enzymes.
Explanation:
Antiretroviral drugs are those used for the treatment of human immunodeficiency virus (HIV) infection, making the effect of the virus on the host cell is less and preventing the development of AIDS.
This type of drug has been classified, according to their mechanism of action, being grouped into several families of drugs. Two different ways by which antiretroviral drugs can prevent the formation of virus are:
- <em><u>Inhibition of reverse transcriptase enzyme</u></em><em>: this enzyme is a DNA polymerase capable of forming single strand viral RNA by a process that is reverse to normal DNA to RNA transcription. Its inhibition prevents the formation of viral particles in the host cell. They are divided into nucleoside analogs and non-nucleoside analogs.</em>
- <em><u>Enzymatic Inhibition of Integrase enzymes</u></em><em>: this type of enzyme is contained in the virus, and is capable of causing a retrotranscribed DNA to integrate into the host cell's DNA so that viral replication occurs. Its inhibition prevents the replication process.</em>
The most effective treatments against HIV infection involve the use of two or more types of antiretroviral drugs.
This question depends on the person. Usually by around 200 to 210, your heart begins to go into an abnormal rhythm or disrythmia, called VT or PVT. The respectively, stand for Ventricular Tachycardia and Pulseless Ventricular Tachycardia (PVT is the more dangerous variety). At around this stage a patient runs the risk of cardiac arrest, which is dangerous because while the heart continues to beat, the contractions are so fast, blood isn't being let into the chambers of the heart. Without blood actually being pumped, the person is unable to perfuse, and goes into shock, seizure, coma, and then death.
Point-of-Sale Drug
Discounts
Beginning in 2019, two health plans will be sharing the drug rebates that pharmaceutical companies give to them. They will be passing the rebates on to the plan members.
Federal Officials proposed a requirement for insurers to
present a fixed percentage of their rebates and use it to reduce Part D
patients' out of pocket prescription costs.
Insurers have expressed disagreement because while it might
decrease healthcare costs for some, it might also increase cost of healthcare
for those who don't use drugs. Also, it may increase the premium rates for
consumers because insurers will not be able to have the funds (rebates
from pharmaceuticals) that they usually retain to keep the premiums low and stable.
